| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Commack, NY, July 24, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) (the "Company") a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, today announced that its board of directors has approved a bridge funding raise of up to an aggregate amount of $3 million, of which it has secured approximately $1.2 million, through the issuance of shares of the Company's common stock to institutional or accredited investors.
The bridge funding does not include any other obligations of the company or issuances of other securities that may have a dilutive effect on existing stockholders, such as warrants, options, or other convertible securities, reflecting the investors' strong support and confidence in the Company's strategy and business plans. The Company intends to allocate the capital to supporting upcoming commercial launches of its products and pipeline program development efforts.
"Obtaining the bridge funding on the most favorable terms possible is crucial as we enter a critical moment in the Company's history," said Shankar Hariharan, Executive Chairman and Co-Chief Executive Officer of the Company. "This represents the investors' belief in our team, our mission, and the future prospects of our Company. We are positioning to execute on our mission of bringing to market solutions that will help transform the lives of patients."
"We are thrilled that sophisticated investors recognize the importance of our mission and the Company's growth prospects," commented Narasimhan Mani, Co-Chief Executive Officer and President. "This commitment will help enable the Company to unlock stockholder value as we execute on our near-term business strategy."
About Scienture Holdings, Inc.
Posted In: SCNX
